KE
Kary Eldred

Kary Eldred insider trades: Galectin Therapeutics (GALT) stock purchases

Galectin Therapeutics Last trade Feb 6, 2026 22 Form 4 filings
$0
Sold, last 12 months
0 sales
$6K
Bought, last 12 months
3 buys
13
Open-market trades
since 2018
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kary reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 6, 2026GALT↑ Buy$810
Dec 23, 2025GALT↑ Buy$3K
Dec 23, 2025GALT↑ Buy$3K
Jul 21, 2025GALT↑ Buy$3K
Dec 24, 2024GALT↑ Buy$11K
Oct 23, 2024GALT↑ Buy$1K
Jan 16, 2024GALT↑ Buy$956
Jan 16, 2024GALT↑ Buy$893
Jul 19, 2023GALT↑ Buy$3K
Feb 21, 2023GALT↑ Buy$2K
Jan 25, 2023GALT↑ Buy$1K
May 31, 2019GALT↑ Buy$13K
Sep 25, 2018GALT↑ Buy$12K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other GALT insiders

Open-market trades in the last 12 months

About Kary Eldred's insider trades

Kary Eldred is an insider at Galectin Therapeutics (GALT). Since Sep 25, 2018, Kary has reported 13 open-market purchases worth $54K and no sales on SEC Form 4. In the last 12 months: 3 buys ($6K).

Their filings also include grants and awards (9 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GALT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.